Icotrokinra vs Melanotan II

Overview

Icotrokinra is primarily a immune support peptide, while Melanotan II is used for cosmetic & skin.

This page compares Icotrokinra and Melanotan II across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. Icotrokinra is categorised under Immune Support, while Melanotan II falls under Cosmetic & Skin. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Icotrokinra: FDA-approved. Melanotan II: not FDA-approved; compounding permitted with a prescription as of April 2026.

Dosing. Typical dosing for Icotrokinra is not catalogued. Melanotan II is typically dosed at 250-500 mcg (as needed).

Can you stack them?

Some protocols combine peptides, but stacking Icotrokinra and Melanotan II has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Icotrokinra and Melanotan II?

Icotrokinra is primarily a immune support peptide, while Melanotan II is used for cosmetic & skin. Icotrokinra is FDA-approved for one or more indications, whereas Melanotan II is not FDA-approved; compounding permitted with a prescription (as of April 2026).

What is Icotrokinra used for?

Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.

What is Melanotan II used for?

Tanning, libido.

Can you take Icotrokinra and Melanotan II together?

Some users combine peptides within a single protocol, but stacking Icotrokinra and Melanotan II has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is Icotrokinra or Melanotan II FDA-approved?

Icotrokinra is FDA-approved for one or more indications. Melanotan II is not FDA-approved; compounding permitted with a prescription (as of April 2026).